[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP0001094A2 - Eljárás naloxon és sói stabilizálására, és naloxont tartalmazó, stabilizált gyógyszerkészítmények - Google Patents

Eljárás naloxon és sói stabilizálására, és naloxont tartalmazó, stabilizált gyógyszerkészítmények

Info

Publication number
HUP0001094A2
HUP0001094A2 HU0001094A HUP0001094A HUP0001094A2 HU P0001094 A2 HUP0001094 A2 HU P0001094A2 HU 0001094 A HU0001094 A HU 0001094A HU P0001094 A HUP0001094 A HU P0001094A HU P0001094 A2 HUP0001094 A2 HU P0001094A2
Authority
HU
Hungary
Prior art keywords
naloxone
stabilization
pharmaceutical compositions
compositions containing
stable pharmaceutical
Prior art date
Application number
HU0001094A
Other languages
English (en)
Inventor
Bernd Raffelsberger
Original Assignee
Gödecke Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gödecke Aktiengesellschaft filed Critical Gödecke Aktiengesellschaft
Publication of HUP0001094A2 publication Critical patent/HUP0001094A2/hu
Publication of HUP0001094A3 publication Critical patent/HUP0001094A3/hu
Publication of HU224964B1 publication Critical patent/HU224964B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Organic Insulating Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya eljárás nalőxőn és sói stabilizálására őldatőkban,valamint szilárd és félig szilárd anyagkeverékekben különösenfőlyékőny és szilárd gyógyszerfőrmákban. A találmány értelmébenszerves vagy szervetlen stabilizátőrt adnak a nalőxőnhőz őlyanmennyiségben, amely meggátőlja a nalőxőnnak 2,2'-dinalőxőnná történődimerizációját. A találmány tővábbi tárgyát képezik a stabilizátőrőkattartalmazó gyógyszerfőrmák. ŕ
HU0001094A 1997-02-14 1998-02-03 Process for stabilization of naloxone and stable pharmaceutical compositions containing naloxone HU224964B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19705537 1997-02-14
PCT/EP1998/000556 WO1998035679A1 (de) 1997-02-14 1998-02-03 Stabilisierung von naloxonhydrochlorid

Publications (3)

Publication Number Publication Date
HUP0001094A2 true HUP0001094A2 (hu) 2000-09-28
HUP0001094A3 HUP0001094A3 (en) 2001-02-28
HU224964B1 HU224964B1 (en) 2006-04-28

Family

ID=7820153

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001094A HU224964B1 (en) 1997-02-14 1998-02-03 Process for stabilization of naloxone and stable pharmaceutical compositions containing naloxone

Country Status (10)

Country Link
EP (1) EP0880352B1 (hu)
AT (1) ATE186643T1 (hu)
CZ (1) CZ297951B6 (hu)
DE (1) DE59800046D1 (hu)
ES (1) ES2141631T3 (hu)
GR (1) GR3032458T3 (hu)
HU (1) HU224964B1 (hu)
PL (1) PL190293B1 (hu)
SK (1) SK282549B6 (hu)
WO (1) WO1998035679A1 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE210983T1 (de) * 1997-11-03 2002-01-15 Stada Arzneimittel Ag Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
RS50070B (sr) 1997-12-22 2009-01-22 Euro-Celtique S.A., Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
PL341309A1 (en) 1997-12-22 2001-04-09 Euro Celtique Method of preventing overdosage of opioidic preparations
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
SI2517710T1 (sl) 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
IL160222A0 (en) 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
EP2289492B1 (en) 2002-03-14 2016-12-07 Euro-Celtique S.A. Naltrexone hydrochloride compositions
ES2546010T3 (es) 2002-04-05 2015-09-17 Euro-Celtique S.A. Preparación farmacéutica que contiene oxicodona y naloxona
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
SI2368553T1 (sl) 2003-04-08 2015-05-29 Progenics Pharmaceuticals, Inc. Farmacevtske formulacije, vsebujoče metilnatrekson
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
HUE031590T2 (hu) 2006-06-19 2017-07-28 Alpharma Pharmaceuticals Llc Gyógyászati készítmények
MX2009011554A (es) 2007-04-26 2010-01-25 Toray Industries Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
CA2740476C (en) 2008-10-24 2016-04-05 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
TR201900199T4 (tr) 2009-03-10 2019-02-21 Euro Celtique Sa Oksikodon ve nalokson içeren çabuk salımlı farmasötik bileşimler.
TWI605814B (zh) 2010-03-11 2017-11-21 惠氏有限責任公司 甲基拿淬松（ｍｅｔｈｙｌｎａｌｔｒｅｘｏｎｅ）之口服製劑及親脂性鹽
ES2642788T3 (es) 2010-05-10 2017-11-20 Euro-Celtique S.A. Fabricación de gránulos sin principio activo y de comprimidos que comprenden los mismos
WO2011141490A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
CA2881144A1 (en) * 2012-11-09 2014-05-09 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
EA030310B1 (ru) 2013-11-13 2018-07-31 Эро-Селтик С.А. Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
WO2015095644A1 (en) 2013-12-20 2015-06-25 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
WO2016007245A1 (en) * 2014-07-08 2016-01-14 Insys Pharma, Inc. Sublingual naloxone spray

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS276692B6 (cs) * 1990-08-29 1992-07-15 Z Presneho Strojirenstvi Zařízení k řazení hřebíků v násypce plníce
JPH07267862A (ja) * 1994-03-29 1995-10-17 Sekisui Chem Co Ltd 経皮吸収貼付剤
DE4423850A1 (de) * 1994-07-07 1996-01-11 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Naloxon
PT914097E (pt) * 1996-03-12 2002-06-28 Alza Corp Composicao e forma de dosagem compreendendo antagonista de opioide

Also Published As

Publication number Publication date
CZ297951B6 (cs) 2007-05-02
SK282549B6 (sk) 2002-10-08
EP0880352A2 (de) 1998-12-02
ES2141631T3 (es) 2000-03-16
CZ289699A3 (cs) 2000-02-16
WO1998035679A1 (de) 1998-08-20
DE59800046D1 (de) 1999-12-23
ATE186643T1 (de) 1999-12-15
EP0880352B1 (de) 1999-11-17
HU224964B1 (en) 2006-04-28
HUP0001094A3 (en) 2001-02-28
PL335249A1 (en) 2000-04-10
PL190293B1 (pl) 2005-11-30
GR3032458T3 (en) 2000-05-31
SK109299A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
HUP0001094A2 (hu) Eljárás naloxon és sói stabilizálására, és naloxont tartalmazó, stabilizált gyógyszerkészítmények
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
HUP0100625A2 (hu) Dibenzilidén-szorbitot és funkcionalizált szilikonokat tartalmazó kozmetikai készítmények
BR9809865A (pt) Fixador de perfume, perfume e produto base misturados com o mesmo, e, produto perfumado.
DE69812343D1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
RU94043772A (ru) Пропинил-диароматические соединения, фармацевтические и косметические составы на их основе
HUP9900717A2 (hu) Szilárd dezodoráló készítmény
KR960034164A (ko) 스틸벤 유도체 및 이를 함유하는 약제학적 조성물
IT1178235B (it) Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione
FI20055562A (fi) Alfa-interferonin stabiilit vesiliuosformulaatit
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
CY1107992T1 (el) Συνθεσεις πολυαμιδο-αμικου οξεος υδατικης βασεως
BR9910016A (pt) Microesferas, processo de preparação das mesmas, e, composições farmacêuticas
FI20000172A (fi) Itse-emulgoituvan valmisteen muodossa oleva farmaseuttinen koostumus happamia lipoifiilisia yhdisteitä varten
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
SE8404065D0 (sv) Novel biologically active compounds
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
DK183789D0 (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
ITMI931685A0 (it) Nuovi derivati di polialchil-4-piperidinoli atti all'impiego come stabilizzanti per materiali organici
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
MX9203140A (es) Derivados de 4 fenil-4(n-(fenil)amido)-piperidina y las composiciones farmaceuticas, asi como el metodo aplicado para tales compuestos.
HUT53481A (en) Process for stabilization of derivatives os izotiasolone
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
HUP9702348A2 (hu) Új, véralvadásgátló hatású glikozidok és az ezeket tartalmazó gyógyszerkészítmények